Utama › Neuropati Sensori dan Autonomi Hereditari › Texas
Kajian klinikal Neuropati Sensori dan Autonomi Hereditari di Texas
11 kajian untuk Neuropati Sensori dan Autonomi Hereditari sedang mencari peserta di lokasi di Texas.
Bandar di Texas
Teks kajian rasmi (Bahasa Inggeris)
Study of ACR-2316 in Specific Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06667141A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Houston Methodist Hospital, Houston
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT07175038A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Clinical Trial Site, San Antonio
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07749586A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Texas Oncology - Central/South Texas, Austin
- Mary Crowley Cancer Research, Dallas
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
- dan 2 lagi
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jul 2026 · NCT04657068First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- University of Texas Southwestern, Dallas
- University of Texas MD Anderson Cancer Center, Houston
- dan 1 lagi
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT05768139Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
- Texas Oncology - Central/South, Austin
- START San Antonio, San Antonio
- Texas Oncology - San Aantonio, San Antonio
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Jul 2026 · NCT07558733Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- START, San Antonio
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jun 2026 · NCT06993844A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
- Texas Oncology - Flower Mound, Flower Mound
Mengambil pesertaFasa 1
Umur 18 ke atas · Wanita · Dikemas kini 22 Apr 2026 · NCT05683418Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
- El Paso Texas Oncology, El Paso
- Texas Oncology San Antonio, San Antonio
Mengambil pesertaKajian pemerhatian
Umur 1 hingga 100 · Semua jantina · Dikemas kini 1 Apr 2026 · NCT05868629A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
- Research Site, Houston
Mengambil pesertaFasa 1
Umur 18 hingga 110 · Semua jantina · Dikemas kini 2 Mac 2026 · NCT07064122Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
- Texas Oncology - West Texas, El Paso
- Texas Oncology - Gulf Coast, The Woodlands
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 24 Dis 2025 · NCT06463028Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.